1. bookVolume 26 (2019): Issue 4 (December 2019)
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English
access type Open Access

Assessment of Common Risk Factors and Lifestyle Habits Associated with Atherogenic Risk and Lipid-Lowering Therapy in Men with Type 2 Diabetes

Published Online: 17 Feb 2020
Page range: 425 - 434
Received: 06 Nov 2019
Accepted: 14 Dec 2019
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English

Background and aims: Our objective was to determine common risk factors and lifestyle habits associated with atherogenic risk and with the use of lipid-lowering therapy in men with type 2 diabetes.

Keywords

1. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2): 88-98, 2018.Search in Google Scholar

2. Magliano DJ, Islam RM, Barr ELM et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ 366: l5003, 2019.Search in Google Scholar

3. Abraham TM, Pencina KM, Pencina MJ et al. Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care 38: 482-487, 2015.Search in Google Scholar

4. International Diabetes Federation. IDF Diabetes Atlas-7th Edition. Diabetes Atlas, 2015.Search in Google Scholar

5. Peela JR, Latiwesh OB, Elshaari F et al. Investigating the Atherogenic Risk of Lipoprotein (a) in Type 2 Diabetic Patients. Cureus 10(7): e3030, 2018.Search in Google Scholar

6. Li Z, Huang Q, Sun L et al. Atherogenic Index in Type 2 Diabetes and its Relationship with Chronic Microvascular Complications. Int J Endocrinol 2018: 1765835, 2018.Search in Google Scholar

7. Xiao C, Dash S, Morgantini C et al. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes 65(7): 1767-1778, 2016.Search in Google Scholar

8. Murad MA, Abdulmageed SS, Iftikhar R et al. Assessment of the common risk factors associated with type 2 diabetes mellitus in jeddah. Int J Endocrinol 2014: 616145, 2014.Search in Google Scholar

9. Bellou V, Belbasis L, Tzoulaki I et al. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS One 13(3): e0194127, 2018.Search in Google Scholar

10. World Health Organization. La mesure de l’obésité-Classification et description des données anthropométriques. Genève: Bibliothèque OMS, EUR/ICP/NUT 125, 1989.Search in Google Scholar

11. SPSS 22.0 (Statistical Package for the Social Sciences, IBM Corporation; Chicago, IL August 2013) software for Windows.Search in Google Scholar

12. Kamari Y, Bitzur R, Cohen H et al. Should all diabetic patients be treated with a statin?. Diabetes Care 32(Suppl 2): S378–S383, 2009.Search in Google Scholar

13. Hammad MA, Syed Sulaiman SA, Aziz NA et al. Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice. J Res Med Sci 24: 15, 2019.Search in Google Scholar

14. Taylor F, Huffman MD, Macedo AF et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013(1): CD004816, 2013.Search in Google Scholar

15. Elnaem MH, Mohamed MHN, Huri HZ et al. Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges. J Pharm Bioallied Sci 9(2): 80-87, 2017.Search in Google Scholar

16. Rabi DM, Edwards AL, Southern DA et al. Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res 6: 124, 2006.Search in Google Scholar

17. Moor I, Spallek J, Richter M. Explaining socioeconomic inequalities in self-rated health: a systematic review of the relative contribution of material, psychosocial and behavioural factors. J Epidemiol Community Health 71(6): 565-575, 2017.Search in Google Scholar

18. Mackenbach JP, Looman CWN, Artnik B et al. ‘Fundamental causes’ of inequalities in mortality: an empirical test of the theory in 20 European populations. Sociol Health Illn 39(7): 1117-1133, 2017.Search in Google Scholar

19. Qi Y, Koster A, van Boxtel M et al. Adulthood Socioeconomic Position and Type 2 Diabetes Mellitus-A Comparison of Education, Occupation, Income, and Material Deprivation: The Maastricht Study. Int J Environ Res Public Health 16(8). pii: E1435, 2019.Search in Google Scholar

20. Cornelis MC, Chiuve SE, Glymour MM et al. Bachelors, Divorcees, and Widowers: Does Marriage Protect Men from Type 2 Diabetes?. PLoS One 9(9): e106720, 2014.Search in Google Scholar

21. Ho K, Jamsen KM, Bell JS et al. Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the Aus Diab study. Eur J Clin Pharmacol 74(11): 1493-1501, 2018.Search in Google Scholar

22. Solanki JD, Makwana AH, Mehta HB et al. Body Mass Index, use of Statins or Current Lipidemic Control: Do they Affect Body Fat Distribution in Sedentary Type 2 Diabetes Mellitus?. J Obes Metab Res 2: 79-83, 2015.Search in Google Scholar

23. Ichikawa R, Daimon M, Miyazaki T et al. Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 12: 38, 2013.Search in Google Scholar

24. Leiter LA, Genest J, Harris SB et al. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Dyslipidemia in Adults with Diabetes. Canadian Journal of Diabetes 30: 230-240, 2006.Search in Google Scholar

25. Pereira T. Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk Factors for Cardiovascular Disease. In Dyslipidemia - From Prevention to Treatment, 279-302, 2012.Search in Google Scholar

26. da Luz PL, Favarato D, Faria-Neto JR Jr et al. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo) 63(4): 427-432, 2008.Search in Google Scholar

27. Nichols GA, Philip S, Reynolds K et al. Increased Residual Cardiovascular Risk in Patients with Diabetes and High vs. Normal Triglycerides Despite Statin-Controlled LDL Cholesterol. Diabetes Obes Metab 21(2): 366-371, 2019.Search in Google Scholar

28. Li H, Lin H, Zhao H et al. Statins use and risk of new-onset diabetes in hypertensive patients: a populationbased retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China. Ther Clin Risk Manag 14: 823-832, 2018.Search in Google Scholar

29. Prugger C, Wellmann J, Heidrich J et al. Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey. Eur J Prev Cardiol 22(9): 1212-1219, 2015.Search in Google Scholar

30. Prugger C, Wellmann J, Heidrich J et al. Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey. Eur Heart J 35(9): 590-598, 2014.Search in Google Scholar

31. Johal S, Jamsen KM, Bell JS et al. Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study. Eur J PrevCardiol 24(6): 621-627, 2017.Search in Google Scholar

32. Lee DS, Markwardt S, Goeres L et al. Statins and physical activity in older men: the osteoporotic fractures in men study. JAMA Intern Med 174(8): 1263-1270, 2014.Search in Google Scholar

33. Bruckert E, Hayem G, Dejager S et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-the PRIMO study. Cardiovasc Drugs Ther 19(6): 403-414, 2005.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo